Search Results

Business

BioMed X Launches New US Institute in New Haven, CT

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

June 13, 2024

·

3 min read

Biotech Bay

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.

May 28, 2024

·

3 min read

Drug Development

BioMed X Start Collaboration in Autoimmunity Research with Servier

The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

June 26, 2024

·

3 min read

Job Trends

New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg

BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany.

April 30, 2024

·

2 min read

Business

BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research

BioMed X announced a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan.

December 19, 2023

·

3 min read

Business

BioMed X and AbbVie Start New Research Project in the USA

BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.

October 31, 2023

·

3 min read

BioMed X Launches a New Call for Application in Autoimmune Disease Research

BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.

November 7, 2023

·

2 min read

Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X

Ono Pharmaceutical Co., Ltd. informed that it has started a new collaboration with BioMed X on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.

January 9, 2024

·

1 min read

SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients

SNIPR Biome ApS (“SNIPR”) announces today that it has received $5.48 million from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (“CARB-X”) to co-fund a Phase 1b/2a clinical trial in hematological cancer patients.

April 22, 2024

·

6 min read

Pharm Country

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024.

May 17, 2024

·

1 min read